When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Single-domain antibody - Wikipedia

   en.wikipedia.org/wiki/Single-domain_antibody

   A single-domain antibody is a peptide chain of about 110 amino acids long, comprising one variable domain (V H) of a heavy-chain antibody, or of a common IgG.These peptides have similar affinity to antigens as whole antibodies, but are more heat-resistant and stable towards detergents and high concentrations of urea.

3. Pramlintide - Wikipedia

   en.wikipedia.org/wiki/Pramlintide

   Pramlintide has been approved on 3/16/2005 by the FDA, for use by type 1 and type 2 diabetic patients who use insulin. [6] (subscription required) Pramlintide allows patients to use less insulin, lowers average blood sugar levels, and substantially reduces what otherwise would be a large unhealthy rise in blood sugar that occurs in diabetics right after eating.

4. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   The US Food and Drug Administration (FDA) approved semaglutide based on evidence from seven clinical trials of 4087 participants with type 2 diabetes. [29] The trials were conducted at 536 sites in 33 countries, including Canada, Mexico, Russia, Ukraine, Turkey, India, South Africa, Japan, Hong Kong, multiple European countries, Argentina, and ...

5. Johnson & Johnson Diabetes Drug Approved by FDA - AOL

   www.aol.com/news/2013-03-29-johnson-johnson...

   The Food and Drug Administration has granted approval to Invokana, a Type 2 diabetes drug manufactured by a unit of Johnson & Johnson . The drug is part of a new class of treatments known as SGLT2 ...

6. FDA approves new version of Eli Lilly’s diabetes drug for ...

   www.aol.com/fda-approves-version-eli-lilly...

   A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced earlier this month. The U.S. Food and Drug Administration approved Eli Lilly ...

7. Diabetes medication - Wikipedia

   en.wikipedia.org/wiki/Diabetes_medication

   There are different classes of hypoglycemic drugs, and selection of the appropriate agent depends on the nature of diabetes, age, and situation of the person, as well as other patient factors. Type 1 diabetes is a disease caused by the lack of insulin. Thus, insulin is the main treatment agent for type 1 and is typically administered via ...